Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Legend Biotech Appoints Alan Bash As Interim Chief Executive Officer

PUBLIC · LEGNJul 27, 202614 days ago

Position

Chief Executive Officer

Company

Legend Biotech

Alan Bash
SomersetBiotechnologyHealth CareTherapeuticsresearch

Description

Legend Biotech has announced the resignation of Ying Huang, Ph.D., as Chief Executive Officer, effective July 24, 2026. Alan Bash has been appointed as the Interim Chief Executive Officer while the Board conducts a search for a permanent successor.

Company Information

Company

Legend Biotech

Location

2101 Cottontail Lane

Somerset, New Jersey, United States

About

Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Our corporate headquarters is located in Somerset, NJ, and our manufacturing footprint includes facilities in the United States, China and the Belgium.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Legend Biotech's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.